Share
Market Research Report

HEMOPHILIA GENE THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Hemophilia TypeHemophilia A · Hemophilia B
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In13 Feb 2026
  • Report CodeCMI2480
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Hemophilia Type
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Pipeline Analysis
    • Primary Research Respondents View About Market
    • Mergers, Acquisitions, and Collaborations
    • Regulatory Scenario
    • PEST Analysis
    • Epidemiological Data
  4. Global Hemophilia Gene Therapy Market, By Hemophilia Type, 2026-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Hemophilia A
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Hemophilia B
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
  5. Global Hemophilia Gene Therapy Market, By Region, 2026-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • North America
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
      • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
      • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
      • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
      • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
      • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Hemophilia Type, 2026 - 2033, (USD Mn)
      • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
        • North Africa
        • Central Africa
        • South Africa
  6. Competitive Landscape

    • Market Share Analysis
    • Company Profiles
      • BioMarin Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Spark Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • UniQure NV
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Ultragenyx Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Shire PLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Sangamo Therapeutics, Inc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Freeline Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  7. Section

    • References
    • Research Methodology
    • About Us and Sales Contact